A blockbuster drug is a therapy that generates at least $1 billion in sales. Clarivate’s Drugs to Watch 2025 report includes ...

The companies Nuvig Therapeutics, Ottimo Pharma, and Angitia Biopharmaceuticals bagged the biggest private biotech ...

Building a biotech startup can be a daunting task and often founders rely on incubators - but how to choose the right one?

GSK took center stage last month, forming standout partnerships and alliances across multiple therapeutic areas.

Explore how biotech breakthroughs in 2024 have changed lives, bringing real Christmas miracles to patients and offering hope ...

Progressing a drug through clinical trials relies on a robust evidence generation plan that includes a strong trial design, accurate patient recruitment and treatment effect assumptions, and ...

Asking whether China is the future of the biotech industry might seem counterintuitive, considering the current biotech geopolitical context. If you haven’t followed this series of events, a ...

Bugworks, which is headquartered in the U.S. with subsidiaries in India and Australia, specializes in the development of antibiotics that could address the growing crisis of antimicrobial resistance.

One of the biggest buyouts last month was Swiss pharma giant Roche’s $1.5 billion dollar acquisition of cell and gene therapy developer Poseida Therapeutics. This will see Roche nab the CAR-T ...